Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance.
Wakabayashi T, Nakatsuji T, Kambara H, Niinomi I, Oyama S, Inada A, Ueno S, Uchida M, Iwanaga K, Iida T, Hosohata K.
Wakabayashi T, et al. Among authors: nakatsuji t.
Curr Rev Clin Exp Pharmacol. 2022;17(2):144-148. doi: 10.2174/1574884716666210215104540.
Curr Rev Clin Exp Pharmacol. 2022.
PMID: 33588740
Free PMC article.